Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3515LS3W
Performance in the last:
Follow this Portfolio
1D -1.1 %
1W 0.2 %
2W 0.3 %
1M -1.8 %
3M -13.2 %
6M -12.8 %
9M -72.3 %
1Y -70.8 %
Alpha
-95.2%
Beta
0.69
sharpe-R
-0.98
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.97
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-10-18 07:52:21
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -75.91%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 3 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 15.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.05% 4.23%
ORGO Organogenesis Holdings Inc. Buy 12.87% -0.32%
ARDX Ardelyx, Inc. Buy 12.37% -3.48%
BKD Brookdale Senior Living Inc. Buy 14% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.79% 7.64%
VCEL Vericel Corporation Buy 12.38% -3.37%
CDXS Codexis, Inc. Buy 12.73% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 12.41% -3.09%
VREX Varex Imaging Corporation Buy 9.35% 0%
NKTR Nektar Therapeutics Buy 9.35% 0%
CUTR Cutera, Inc. Sell -5.26% 12%
FATE Fate Therapeutics, Inc. Sell -6% -0.31%
ORMP Oramed Pharmaceuticals Inc. Sell -6.01% -0.42%
IRTC iRhythm Technologies, Inc. Sell -6.03% 0.35%
The percentage of cash held in the portfolio is: 2%
** The description of each asset is available Here

The latest 5 Compositions change

2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 12.05% 4.23%
ORGO Organogenesis Holdings Inc. Buy 12.87% -0.32%
ARDX Ardelyx, Inc. Buy 12.37% -3.48%
BKD Brookdale Senior Living Inc. Buy 14% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.79% 7.64%
VCEL Vericel Corporation Buy 12.38% -3.37%
CDXS Codexis, Inc. Buy 12.73% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 12.41% -3.09%
VREX Varex Imaging Corporation Buy 9.35% 0%
NKTR Nektar Therapeutics Buy 9.35% 0%
CUTR Cutera, Inc. Sell -5.26% 12%
FATE Fate Therapeutics, Inc. Sell -6% -0.31%
ORMP Oramed Pharmaceuticals Inc. Sell -6.01% -0.42%
IRTC iRhythm Technologies, Inc. Sell -6.03% 0.35%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • VREX
  • NKTR
Assets Removed
Asset Action Perf %
AXSM Buy All -7.81%
RDNT Sell All -3.2%
Assets Rebalanced
None
2024-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.78% 3.05%
ORGO Organogenesis Holdings Inc. Buy 13.26% 3.9%
ARDX Ardelyx, Inc. Buy 12.52% -1.16%
BKD Brookdale Senior Living Inc. Buy 12.71% 0.33%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 13.01% 2.69%
VCEL Vericel Corporation Buy 12.63% -0.33%
RDNT RadNet, Inc. Buy 12.69% 0.2%
CDXS Codexis, Inc. Buy 12.66% 0%
SGMO Sangamo Therapeutics, Inc. Buy 12.66% 0%
CUTR Cutera, Inc. Sell -5.44% 8%
FATE Fate Therapeutics, Inc. Sell -5.62% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -5.82% 1.67%
IRTC iRhythm Technologies, Inc. Sell -5.74% 4.11%
AXSM Axsome Therapeutics, Inc. Sell -5.97% 0.18%
The percentage of cash held in the portfolio is: 14.66%
New Assets Added
  • CDXS
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.63% 0.7%
ORGO Organogenesis Holdings Inc. Buy 12.94% 0.32%
ARDX Ardelyx, Inc. Buy 12.69% -0.83%
BKD Brookdale Senior Living Inc. Buy 12.8% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 12.8% 0%
VCEL Vericel Corporation Buy 12.8% 0%
RDNT RadNet, Inc. Buy 12.8% 0%
CUTR Cutera, Inc. Sell -5.66% 5.33%
FATE Fate Therapeutics, Inc. Sell -5.68% 4.98%
ORMP Oramed Pharmaceuticals Inc. Sell -5.95% 0.42%
IRTC iRhythm Technologies, Inc. Sell -5.58% 7.61%
AXSM Axsome Therapeutics, Inc. Sell -5.96% 1.35%
The percentage of cash held in the portfolio is: 40.39%
New Assets Added
  • BKD
  • ARWR
  • VCEL
  • RDNT
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.62% 0%
ORGO Organogenesis Holdings Inc. Buy 12.93% -0.32%
ARDX Ardelyx, Inc. Buy 12.87% 0%
CUTR Cutera, Inc. Sell -6.09% -1.33%
FATE Fate Therapeutics, Inc. Sell -5.79% 3.74%
ORMP Oramed Pharmaceuticals Inc. Sell -5.99% 0.42%
IRTC iRhythm Technologies, Inc. Sell -5.53% 8.99%
AXSM Axsome Therapeutics, Inc. Sell -6.15% -1.12%
The percentage of cash held in the portfolio is: 92.12%
New Assets Added
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.44% -1.17%
ORGO Organogenesis Holdings Inc. Buy 12.67% -1.95%
CUTR Cutera, Inc. Sell -5.83% 2.67%
FATE Fate Therapeutics, Inc. Sell -5.48% 8.41%
ORMP Oramed Pharmaceuticals Inc. Sell -6.01% -0.42%
IRTC iRhythm Technologies, Inc. Sell -5.54% 8.5%
AXSM Axsome Therapeutics, Inc. Sell -5.81% 4.05%
The percentage of cash held in the portfolio is: 104.57%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -6.07%
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.69% 0.94%
BCRX BioCryst Pharmaceuticals, Inc. Buy 12.92% 0%
ORGO Organogenesis Holdings Inc. Buy 12.92% 0%
CUTR Cutera, Inc. Sell -5.99% 0%
FATE Fate Therapeutics, Inc. Sell -6.01% -0.31%
ORMP Oramed Pharmaceuticals Inc. Sell -5.89% 1.67%
IRTC iRhythm Technologies, Inc. Sell -6.06% 0%
AXSM Axsome Therapeutics, Inc. Sell -6.06% 0%
The percentage of cash held in the portfolio is: 92.47%
New Assets Added
  • IRTC
  • AXSM
  • BCRX
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 11.6% 0%
CUTR Cutera, Inc. Sell -6% 0%
FATE Fate Therapeutics, Inc. Sell -6% 0%
ORMP Oramed Pharmaceuticals Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 106.4%
New Assets Added
  • CUTR
  • FATE
  • ORMP
  • IRWD
Assets Removed
None
Assets Rebalanced
None
2024-09-26 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Buy All 0.6%
CERS Buy All 16.11%
NVCR Sell All -11.63%
Assets Rebalanced
None
2024-09-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 18.96% -8.98%
VREX Varex Imaging Corporation Sell -5.63% 5.21%
CERS Cerus Corporation Sell -5.06% 14.69%
The percentage of cash held in the portfolio is: 91.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
MYGN Sell All -1.56%
Assets Rebalanced
None
2024-09-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 19.09% -8.42%
MYGN Myriad Genetics, Inc. Buy 9.04% -0.15%
VREX Varex Imaging Corporation Sell -5.99% -0.77%
CERS Cerus Corporation Sell -5.01% 15.64%
The percentage of cash held in the portfolio is: 82.87%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -10.93%
Assets Rebalanced
None
2024-09-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
ESPR Esperion Therapeutics, Inc. Buy 4.92% -4.92%
NVCR NovoCure Limited Buy 19.85% -2.44%
MYGN Myriad Genetics, Inc. Buy 9.33% 5.56%
VREX Varex Imaging Corporation Sell -5.46% 5.73%
CERS Cerus Corporation Sell -4.89% 15.64%
The percentage of cash held in the portfolio is: 76.26%
New Assets Added
None
Assets Removed
Asset Action Perf %
AVXL Buy All 6.46%
PODD Sell All 15.5%
Assets Rebalanced
None
2024-09-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 24.76% 15.22%
ESPR Esperion Therapeutics, Inc. Buy 5.03% -2.73%
NVCR NovoCure Limited Buy 20.3% -0.17%
MYGN Myriad Genetics, Inc. Buy 9.37% 6.04%
AVXL Anavex Life Sciences Corp. Sell -5.54% 7.14%
VREX Varex Imaging Corporation Sell -5.5% 5.04%
CERS Cerus Corporation Sell -5.41% 6.64%
The percentage of cash held in the portfolio is: 56.98%
New Assets Added
None
Assets Removed
Asset Action Perf %
STAA Buy All 0.59%
Assets Rebalanced
None
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 24.86% 14.42%
ESPR Esperion Therapeutics, Inc. Buy 5.03% -3.83%
NVCR NovoCure Limited Buy 20.45% -0.5%
MYGN Myriad Genetics, Inc. Buy 9.24% 3.45%
STAA STAAR Surgical Company Sell -6.11% 3.06%
AVXL Anavex Life Sciences Corp. Sell -5.84% 3.06%
VREX Varex Imaging Corporation Sell -5.77% 1.45%
CERS Cerus Corporation Sell -5.72% 2.37%
The percentage of cash held in the portfolio is: 63.86%
New Assets Added
None
Assets Removed
Asset Action Perf %
AADI Sell All 7.43%
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 11.78% 2.86%
PODD Insulet Corporation Buy 24.83% 14.41%
TVTX Travere Therapeutics, Inc. Buy 7.34% 40.42%
ESPR Esperion Therapeutics, Inc. Buy 5.46% 4.37%
NVCR NovoCure Limited Buy 21.13% 2.88%
MYGN Myriad Genetics, Inc. Buy 9.12% 2.3%
STAA STAAR Surgical Company Sell -6.29% -0.03%
AVXL Anavex Life Sciences Corp. Sell -5.44% 9.69%
VREX Varex Imaging Corporation Sell -5.91% -1.03%
CERS Cerus Corporation Sell -5.74% 1.9%
The percentage of cash held in the portfolio is: 43.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
CDMO Buy All -5.48%
Assets Rebalanced
None
2024-09-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 11.88% 1.14%
PODD Insulet Corporation Buy 25.09% 12.73%
TVTX Travere Therapeutics, Inc. Buy 7.04% 31.25%
ESPR Esperion Therapeutics, Inc. Buy 5.13% -4.37%
NVCR NovoCure Limited Buy 20.22% -3.99%
MYGN Myriad Genetics, Inc. Buy 8.95% -2.15%
CDMO Avid Bioservices, Inc. Sell -6.83% -5.48%
STAA STAAR Surgical Company Sell -5.97% 7.41%
AVXL Anavex Life Sciences Corp. Sell -5.47% 11.39%
VREX Varex Imaging Corporation Sell -5.89% 1.88%
CERS Cerus Corporation Sell -5.8% 3.32%
The percentage of cash held in the portfolio is: 51.67%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All 8.41%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings